Quantinno Capital Management LP Avidity Biosciences, Inc. Transaction History
Quantinno Capital Management LP
- $7.54 Billion
- Q3 2024
A detailed history of Quantinno Capital Management LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Quantinno Capital Management LP holds 6,508 shares of RNA stock, worth $269,105. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,508
Previous 6,588
1.21%
Holding current value
$269,105
Previous $269,000
10.78%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RNA
# of Institutions
256Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$440 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$382 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$357 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$336 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$291 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.16B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...